NPSA has called for a more robust assessment of the role Australia’s full-line wholesalers play in the delivery of the National Medicines Policy (NMP) in its response to the Review of Pharmacy Regulation and Remuneration’s Interim Report. Read the response here: Final Response to the Interim Report - 28 July 17 (redacted) … [Read more...]
Review of Pharmacy Remuneration and Regulation
In its submissions to the Review, NPSA makes the case for why medicines wholesaling in Australia has worked so well up to now; what is at risk if the status quo is maintained; and how wholesaling under the PBS can be improved. A briefing note is here. NPSA’s submissions to the Review are here and here. A link to the Interim Report from the … [Read more...]
‘In stock’ – by Michael Tatchell in the AJP
Dr Michael Tatchell examines the importance the CSO plays in patient healthcare. To read the article click here Michael Tatchell AJP article September 2013.pdf The Australian Journal of Pharmacy vol.100 September 2013 … [Read more...]
‘Lessons from overseas’ by Michael Tatchell in the AJP
Dr Michael Tatchell examines pharmaceutical wholesaling in the UK, Europe and the United States and asks what lessons Australia can learn from their experiences. To read the article click here Michael Tatchell AJP article August 2013.pdf The Australian Journal of Pharmacy vol.99 August 2013 … [Read more...]
’24 hours’ by Michael Tatchell in the AJP
Dr Michael Tatchell speaks to employees of Symbion to illustrate the lengths to which the wholesalers go to ensure medicines make it to pharmacies – and to patients – within 24 hours of the pharmacy order’s cut off time. To read the article click here Michael Tatchell AJP article June 2013.pdf. Published in The Australian Journal of … [Read more...]